DESCRIPTION

Encoding: UTF-8
Package: replicateBE
Version: 1.1.3.9000
Date: 2022-05-03
Title: Average Bioequivalence with Expanding Limits (ABEL)
Authors@R: c(person(given = "Helmut", family = "Schütz",
                    role = c("aut", "cre"),
                    email = "helmut.schuetz@bebac.at",
                    comment = c(ORCID = "0000-0002-1167-7880")),
             person(given = "Michael", family = "Tomashevskiy",
                    role = "ctb",
                    email = "mittyright@yandex.ru"),
             person(given = "Detlew", family = "Labes",
                    role = "ctb",
                    email = "DetlewLabes@gmx.de",
                    comment = c(ORCID = "0000-0003-2169-426X")))
Author: Helmut Schütz [aut, cre] (<https://orcid.org/0000-0002-1167-7880>),
    Michael Tomashevskiy [ctb],
    Detlew Labes [ctb] (<https://orcid.org/0000-0003-2169-426X>)
Maintainer: Helmut Schütz <helmut.schuetz@bebac.at>
Authors: (2020) <doi:10.1208/s12248-020-0427-6>
Depends: R (>= 3.5.0)
Imports: readxl (>= 1.0.0), PowerTOST (>= 1.5.3), lmerTest, nlme, pbkrtest,
    graphics, grDevices
Suggests: knitr, rmarkdown, testthat, devtools
Description: Performs comparative bioavailability calculations for Average
    Bioequivalence with Expanding Limits (ABEL). Implemented are 'Method A' /
    'Method B' and the detection of outliers. If the design allows, assessment
    of the empiric Type I Error and iteratively adjusting alpha to control the
    consumer risk. Average Bioequivalence - optionally with a tighter (narrow
    therapeutic index drugs) or wider acceptance range (South Africa: Cmax) -
    is implemented as well.
License: GPL (>=3)
LazyData: true
VignetteBuilder: knitr
URL: https://github.com/Helmut01/replicateBE
BugReports: https://github.com/Helmut01/replicateBE/issues